Pieter J Tanis Selected Research

Proctectomy

11/2022	Mesh, flap or combined repair of perineal hernia after abdominoperineal resection - A systematic review and meta-analysis.
1/2022	Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study).
11/2021	Quantifying displacement of urogenital organs after abdominoperineal resection for rectal cancer.
4/2021	Dorsal approach with tailored partial sacrectomy and gluteal V-Y fasciocutaneous advancement flap for the management of recurrent pelvic sepsis; case report.
1/2021	Persistent High Rate of Positive Margins and Postoperative Complications After Surgery for cT4 Rectal Cancer at a National Level.
7/2020	Perineal wound closure using gluteal turnover flap or primary closure after abdominoperineal resection for rectal cancer: study protocol of a randomised controlled multicentre trial (BIOPEX-2 study).
1/2020	A Systematic Review and Meta-analysis on Omentoplasty for the Management of Abdominoperineal Defects in Patients Treated for Cancer.
11/2019	CT assessment of the quality of omentoplasty and its implications for perineal wound healing.
4/2019	Low Hartmann's procedure or intersphincteric abdominoperineal resection in the primary treatment of low rectal cancer; a survey among surgeons evaluating current practice.
1/2019	Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn's Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pieter J Tanis Research Topics

Disease

31	Rectal Neoplasms (Rectal Cancer) 01/2022 - 01/2011
25	Neoplasms (Cancer) 05/2022 - 02/2007
19	Colonic Neoplasms (Colon Cancer) 01/2022 - 09/2013
15	Neoplasm Metastasis (Metastasis) 03/2022 - 03/2015
11	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2013
7	Wounds and Injuries (Trauma) 01/2022 - 08/2014
7	Anastomotic Leak 01/2022 - 01/2012
6	Ulcerative Colitis 11/2017 - 02/2012
5	Hernia (Hernias) 11/2022 - 08/2014
4	Margins of Excision 01/2021 - 02/2007
3	Carcinoma (Carcinomatosis) 05/2022 - 03/2008
3	Sepsis (Septicemia) 04/2021 - 03/2013
3	Adenocarcinoma 01/2019 - 12/2011
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2016 - 02/2012
2	Appendicitis 10/2021 - 01/2020
2	Crohn Disease (Crohn's Disease) 01/2019 - 03/2016
2	Disease Progression 01/2016 - 03/2015
2	Pain (Aches) 02/2014 - 02/2012
2	Breast Neoplasms (Breast Cancer) 11/2008 - 02/2007
1	Prolapse 01/2022
1	Peritoneal Diseases 07/2021
1	Abscess 04/2021
1	Obesity 01/2021
1	Lymphatic Metastasis 01/2021
1	Hyperthermia 01/2020
1	Peritoneal Fibrosis 10/2019
1	Anemia 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2018
1	Fistula 07/2016
1	Necrosis 07/2016
1	Overweight 07/2016
1	Weight Loss (Weight Reduction) 07/2016
1	Pouchitis 03/2016
1	Abdominal Abscess 10/2015
1	Peritoneal Neoplasms 05/2015
1	Hypersensitivity (Allergy) 08/2014
1	Postoperative Pain 11/2013
1	Incisional Hernia 02/2012

Drug/Important Bio-Agent (IBA)

5	Biological ProductsIBA 11/2022 - 08/2014
3	BiopexIBA 01/2022 - 08/2014
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2020 - 01/2019
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 12/2021 - 07/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 03/2016
2	SteroidsIBA 07/2016 - 07/2016
2	Coloring Agents (Dyes)IBA 11/2008 - 02/2007
1	C-Reactive ProteinIBA 05/2022
1	CreatinineIBA 05/2022
1	SolutionsIBA 07/2021
1	Decitabine FDA Link 05/2021
1	DNA (Deoxyribonucleic Acid)IBA 05/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 02/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2020
1	PlatinumIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	mesoglycanIBA 01/2018
1	CollagenIBA 08/2014
1	Polysorbates (PSML)FDA Link 08/2014
1	Infliximab (Remicade)FDA Link 03/2013
1	cyclo(Arg-Pro) (CI 4)IBA 03/2013
1	Morphine (MS Contin)FDA LinkGeneric 02/2012
1	Capecitabine (Xeloda)FDA Link 12/2011

Therapy/Procedure

21	Proctectomy 11/2022 - 02/2012
12	Hyperthermic Intraperitoneal Chemotherapy 03/2022 - 05/2015
12	Neoadjuvant Therapy 01/2022 - 12/2011
12	Radiotherapy 01/2022 - 01/2011
11	Therapeutics 01/2022 - 12/2011
8	Cytoreduction Surgical Procedures 03/2022 - 01/2019
7	Restorative Proctocolectomy 12/2019 - 02/2012
6	Self Expandable Metallic Stents 05/2022 - 11/2014
6	Colectomy 05/2022 - 02/2012
4	Ileostomy 01/2022 - 01/2012
4	Appendectomy 10/2021 - 03/2015
4	Length of Stay 10/2021 - 11/2013
4	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 03/2008
4	Stents 01/2020 - 11/2014
4	Drug Therapy (Chemotherapy) 01/2020 - 12/2018
3	Minimally Invasive Surgical Procedures 01/2022 - 01/2021
3	Aftercare (After-Treatment) 01/2021 - 01/2018
3	Chemoradiotherapy 12/2019 - 01/2019
3	Adjuvant Chemotherapy 01/2019 - 03/2015
2	Colostomy 11/2021 - 10/2015
2	Adjuvant Radiotherapy 04/2021 - 08/2014
2	Operative Surgical Procedures 01/2020 - 12/2017
2	Pancreaticoduodenectomy 10/2018 - 01/2016
2	Operative Time 11/2013 - 02/2012
1	Ostomy 01/2022
1	Conversion to Open Surgery 10/2021
1	Duration of Therapy 07/2021
1	Debridement 04/2021
1	Immunotherapy 10/2019
1	Perioperative Care 01/2019
1	Contraindications 12/2017
1	Blood Transfusion (Blood Transfusions) 07/2016
1	Analgesia 11/2013
1	Colonic Pouches (S Pouch) 03/2013
1	Herniorrhaphy 02/2012
1	Organ Sparing Treatments 01/2011